147 related articles for article (PubMed ID: 15117734)
1. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.
Baroukh N; Bauge E; Akiyama J; Chang J; Afzal V; Fruchart JC; Rubin EM; Fruchart-Najib J; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1297-302. PubMed ID: 15117734
[TBL] [Abstract][Full Text] [Related]
2. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
van Dijk KW; Rensen PC; Voshol PJ; Havekes LM
Curr Opin Lipidol; 2004 Jun; 15(3):239-46. PubMed ID: 15166778
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
Pennacchio LA; Rubin EM
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):529-34. PubMed ID: 12615678
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
Fruchart-Najib J; Baugé E; Niculescu LS; Pham T; Thomas B; Rommens C; Majd Z; Brewer B; Pennacchio LA; Fruchart JC
Biochem Biophys Res Commun; 2004 Jun; 319(2):397-404. PubMed ID: 15178420
[TBL] [Abstract][Full Text] [Related]
5. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.
Pennacchio LA; Olivier M; Hubacek JA; Cohen JC; Cox DR; Fruchart JC; Krauss RM; Rubin EM
Science; 2001 Oct; 294(5540):169-73. PubMed ID: 11588264
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants.
Hubacek JA
Clin Chem Lab Med; 2005; 43(9):897-902. PubMed ID: 16176166
[TBL] [Abstract][Full Text] [Related]
7. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
8. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
[TBL] [Abstract][Full Text] [Related]
9. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
11. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
12. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
[TBL] [Abstract][Full Text] [Related]
13. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
Ebara T; Ramakrishnan R; Steiner G; Shachter NS
J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
[TBL] [Abstract][Full Text] [Related]
14. [Apolipoprotein AV and triglyceridemia].
Hubácek JA
Cas Lek Cesk; 2004; 143(12):799-803. PubMed ID: 15730209
[TBL] [Abstract][Full Text] [Related]
15. Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia.
Vaessen SF; Sierts JA; Kuivenhoven JA; Schaap FG
Biochem Biophys Res Commun; 2009 Feb; 379(2):542-6. PubMed ID: 19121291
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
[TBL] [Abstract][Full Text] [Related]
17. In vivo characterization of human APOA5 haplotypes.
Ahituv N; Akiyama J; Chapman-Helleboid A; Fruchart J; Pennacchio LA
Genomics; 2007 Dec; 90(6):674-9. PubMed ID: 17936576
[TBL] [Abstract][Full Text] [Related]
18. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
Dorfmeister B; Brandlhofer S; Schaap FG; Hermann M; Fürnsinn C; Hagerty BP; Stangl H; Patsch W; Strobl W
Diabetologia; 2006 Jun; 49(6):1324-32. PubMed ID: 16570166
[TBL] [Abstract][Full Text] [Related]
20. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men.
Baum L; Tomlinson B; Thomas GN
Clin Genet; 2003 May; 63(5):377-9. PubMed ID: 12752569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]